CNS Pharmaceuticals’ $4 Million Common Stock Offering

ArentFox Schiff advised CNS Pharmaceuticals, while Sullivan & Worcester advised the placement agents on the offering.CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now